Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00036270
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2002-05-08
Brief Title:
Randomized Phase III Study Of Exemestane Aromasin For 5 Years Versus Tamoxifen for 25 to 3 Years Followed By Exemestane
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
971-ONC-0028-081
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None